Brief: Werewolf Therapeutics Reports Q3 2022 Results

Werewolf Therapeutics

10/11/2022 12:28

Nov 10 (Reuters) - Werewolf Therapeutics Inc  HOWL.O :
    * WEREWOLF THERAPEUTICS REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
    * REMAINS WELL-CAPITALIZED WITH RUNWAY THAT WILL CARRY CO
THROUGH
AT LEAST Q2 OF 2024
    * WEREWOLF THERAPEUTICS - AS OF SEPTEMBER 30, 2022, CASH AND
CASH
EQUIVALENTS DECREASED TO $140.5 MILLION, COMPARED TO $157.5
MILLION AS OF DECEMBER 31, 2021
    * QTRLY LOSS PER SHARE $0.40
    * Q3 EARNINGS PER SHARE VIEW $-0.60 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX4Drnwx 
Further company coverage:  HOWL.O 
 ((Reuters.Briefs@thomsonreuters.com;))